ADCT logo

ADC Therapeutics SA (ADCT)

Profile

Full Name

ADC Therapeutics SA

Ticker Symbol

ADCT

Exchange

NYSE

Sector

Healthcare

Industry

Biotechnology

Country

Switzerland

IPO

May 18, 2020

Indexes

Not included

Website

http://www.adctherapeutics.com

Employees

263

Key Details

Price

$1.21(0.00%)

Market cap

$119.89M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$70.84M(+1.84% YoY)

Annual EPS

-$1.62(+44.90% YoY)

PE ratio

-

Next earnings date

May 6, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.21
ADCT price is $1.21

30-Day Relative Volume

0.67
ADCT 30-day relative volume is 0.67

Price Performance

Price Most recent change

0%
ADCT {parameterFullLabel} has remained unchanged on Apr 15, 2025

Price YTD change

-39.2%
ADCT price is down -39.2% since January 1st

Price 1-year change

-72.31%
ADCT price is down -72.31% year-on-year

Price 3-year change

-91.47%
ADCT price is down -91.47% over the past 3 years

Price Range

Price All-time high

$56.59
ADCT price is currently -97.86% below its historical high of $56.59

Price 3-year low

$0.36
ADCT price is currently +236.11% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$119.89M
ADCT market capitalization is $119.89 million

Market cap 3-year change

-89%
ADCT market capitalization is down -89% over the past 3 years

Market cap All-time high

$3.61B
ADCT market capitalization is currently -96.68% below its historical high of $3.61 billion

Market cap sector rank

50.49%
ADCT market capitalization is higher than 50.49% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+19.65%
ADCT shares outstanding is up +19.65% year-on-year

Shares Outstanding 3-Year Change

+29%
ADCT shares outstanding is up +29% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.29
ADCT beta is 1.29

200-day SMA

$2.44
ADCT price is currently -50.38% below its 200-day simple moving average

50-day SMA

$1.55
ADCT price is currently -22.15% below its 50-day simple moving average

RSI

37.75
ADCT 14-day relative strength index is 37.75

Volume

0.67
ADCT 30-day relative volume is 0.67

ATR

$0.12
ADCT average true range is $0.12

10-day Historical Volatility

97.43%
ADCT 10-day historical volatility is 97.43%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$70.84M
ADCT annual revenue is $70.84 million

Revenue Analysts estimate

$73.43M
ADCT annual revenue is currently -3.53% lower than the consensus analysts' forecast

Revenue 1-year change

+1.84%
ADCT annual revenue is up +1.84% year-on-year

Revenue Sector rank

52.07%
ADCT annual revenue is higher than 52.07% of companies in Healthcare sector

EPS

EPS

-$1.62
ADCT annual earnings per share is -$1.62

EPS Analysts estimate

-
ADCT annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

+44.9%
ADCT annual earnings per share is up +44.9% year-on-year

EPS Sector rank

43.33%
ADCT annual earnings per share is higher than 43.33% of companies in Healthcare sector

Profit

Gross profit

$64.89M
ADCT annual gross profit is $64.89 million

Gross margin

91.60%
ADCT annual gross profit margin is 91.60%

Operating profit

-$129.59M
ADCT annual operating income is -$129.59 million

Operating margin

-182.94%
ADCT annual operating profit margin is -182.94%

Net income

-$157.85M
ADCT annual net profit is -$157.85 million

Net margin

-222.83%
ADCT annual net profit margin is -222.83%

Expenses

Total expenses

$200.43M
ADCT annual total expenses is $200.43 million

Operating expenses

$194.48M
ADCT annual total operating expenses is $194.48 million

Cost of goods sold

$5.95M
ADCT annual cost of goods sold is $5.95 million

Selling, general & administrative expenses

$85.91M
ADCT annual SGA is $85.91 million

Depreciation and amortization

$3.28M
ADCT annual depreciation & amortization is $3.28 million

Interest expense

$50.21M
ADCT annual interest expense is $50.21 million

Income tax

$166.00K
ADCT annual income tax is $166.00 thousand

EBIT & EBITDA

EBIT

-$105.92M
ADCT annual earnings before interest & taxes is -$105.92 million

EBITDA

-$102.65M
ADCT annual EBITDA is -$102.65 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$321.98M
ADCT annual total assets is $321.98 million

Non current assets

$14.59M
ADCT annual long term assets is $14.59 million

Current assets

$307.39M
ADCT annual total current assets is $307.39 million

Cash and cash equivalents

$250.87M
ADCT annual cash & cash equivalents is $250.87 million

Accounts receivable

$20.32M
ADCT annual accounts receivable is $20.32 million

Inventory

$18.39M
ADCT annual inventory is $18.39 million

Liabilities

Total liabilities

$524.62M
ADCT annual total liabilities is $524.62 million

Long term liabilities

$444.15M
ADCT annual total long term liabilities is $444.15 million

Current liabilities

$80.47M
ADCT annual total current liabilities is $80.47 million

Accounts payable

$18.03M
ADCT annual accounts payable is $18.03 million

Debt

Total debt

$123.00M
ADCT annual total debt is $123.00 million

Total debt 1-year change

-1.11%
ADCT annual total debt is down -1.11% year-on-year

Long term debt

$121.63M
ADCT annual long term debt is $121.63 million

Short term debt

$1.37M
ADCT annual short term debt is $1.37 million

Equity & Capital

Shareholders equity

-$202.64M
ADCT annual stockholders equity is -$202.64 million

Book value

-$202.64M
ADCT annual book value is -$202.64 million

Retained earnings

-$1.49B
ADCT annual retained earnings is -$1.49 billion

Working capital

$226.92M
ADCT annual working capital is $226.92 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$123.83M
ADCT annual cash flow from operations is -$123.83 million

Cash from operations 1-year change

-4.34%
ADCT annual cash flow from operations is down -4.34% year-on-year

Cash from investing

-$867.00K
ADCT annual cash flow from investing activities is -$867.00 thousand

Cash from investing 1-year change

+73.04%
ADCT annual cash flow from investing activities is up +73.04% year-on-year

Cash from financing

$97.05M
ADCT annual cash flow from financing activities is $97.05 million

Cash from financing 1-year change

+31.38%
ADCT annual cash flow from financing activities is up +31.38% year-on-year

CAPEX

CAPEX

$867.00K
ADCT annual capital expenditures is $867.00 thousand

CAPEX 1-year change

-73.04%
ADCT annual capital expenditures is down -73.04% year-on-year

Free Cash Flow

Free cash flow

-$124.70M
ADCT annual free cash flow is -$124.70 million

Free cash flow 1-year change

-2.3%
ADCT annual free cash flow is down -2.3% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

91.60%
ADCT annual gross profit margin is 91.60%

Operating margin

-182.94%
ADCT annual operating profit margin is -182.94%

Net margin

-222.83%
ADCT annual net profit margin is -222.83%

ROA & ROE

ROA

-46.65%
ADCT annual return on assets is -46.65%

ROE

77.89%
ADCT annual return on equity is 77.89%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
ADCT price to earnings ratio value is unknown

PE ratio Sector rank

-
ADCT price to earnings ratio is unknown

PB Ratio

PB ratio

-0.59
ADCT price to book ratio is -0.59

PB ratio Sector rank

10.29%
ADCT price to book ratio is higher than 10.29% of companies in Healthcare sector

PS Ratio

PS ratio

1.69
ADCT price to sales ratio is 1.69

PS ratio Sector rank

38.97%
ADCT price to sales ratio is higher than 38.97% of companies in Healthcare sector

Enterprise value

Enterprise value

-$7.98M
ADCT enterprise value is -$7.98 million

Enterprise value Sector rank

5.05%
ADCT enterprise value is higher than 5.05% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

0.08
ADCT EV/EBITDA is 0.08

EV/EBITDA Sector rank

66.58%
ADCT EV/EBITDA is higher than 66.58% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

3.82
ADCT annual current ratio is 3.82

Quick ratio

3.59
ADCT annual quick ratio is 3.59

Leverage

Debt to equity

-0.56
ADCT annual debt to equity ratio is -0.56

Interest coverage ratio

-2.11
ADCT annual interest coverage ratio is -2.11

Risk & Stability

Piotroski F-Score

3
ADCT piotroski f-score is 3

Altman Z-Score

-6.38
ADCT altman z-score is -6.38

Analyst ratings

Recent major analysts updates

Mar 31, 25 HC Wainwright & Co.
Buy
Mar 31, 25 Guggenheim
Buy
Mar 7, 25 Cantor Fitzgerald
Overweight
Feb 24, 25 Stephens & Co.
Overweight
Jan 6, 25 HC Wainwright & Co.
Buy
Dec 12, 24 Guggenheim
Buy
Dec 11, 24 HC Wainwright & Co.
Buy
Nov 8, 24 Stephens & Co.
Overweight
Aug 8, 24 HC Wainwright & Co.
Buy
Aug 7, 24 RBC Capital
Outperform

Institutional Ownership

Similar stocks

Eupraxia Pharmaceuticals (EPRX)
LRMR logo
Larimar Therapeutics (LRMR)
NKTR logo
Nektar Therapeutics (NKTR)
Kalaris Therapeutics (KLRS)
ACRS logo
Aclaris Therapeutics (ACRS)
NKTX logo
Nkarta (NKTX)
KOD logo
Kodiak Sciences (KOD)
GLSI logo
Greenwich LifeSciences (GLSI)
THTX logo
Theratechnologies (THTX)
  • What is the ticker symbol for ADC Therapeutics SA?
  • Does ADC Therapeutics SA pay dividends?
  • What sector is ADC Therapeutics SA in?
  • What industry is ADC Therapeutics SA in?
  • What country is ADC Therapeutics SA based in?
  • When did ADC Therapeutics SA go public?
  • Is ADC Therapeutics SA in the S&P 500?
  • Is ADC Therapeutics SA in the NASDAQ 100?
  • Is ADC Therapeutics SA in the Dow Jones?
  • When was ADC Therapeutics SA's last earnings report?
  • When does ADC Therapeutics SA report earnings?
  • Should I buy ADC Therapeutics SA stock now?

What is the ticker symbol for ADC Therapeutics SA?

The ticker symbol for ADC Therapeutics SA is NYSE:ADCT

Does ADC Therapeutics SA pay dividends?

No, ADC Therapeutics SA does not pay dividends

What sector is ADC Therapeutics SA in?

ADC Therapeutics SA is in the Healthcare sector

What industry is ADC Therapeutics SA in?

ADC Therapeutics SA is in the Biotechnology industry

What country is ADC Therapeutics SA based in?

ADC Therapeutics SA is headquartered in Switzerland

When did ADC Therapeutics SA go public?

ADC Therapeutics SA's initial public offering (IPO) was on May 18, 2020

Is ADC Therapeutics SA in the S&P 500?

No, ADC Therapeutics SA is not included in the S&P 500 index

Is ADC Therapeutics SA in the NASDAQ 100?

No, ADC Therapeutics SA is not included in the NASDAQ 100 index

Is ADC Therapeutics SA in the Dow Jones?

No, ADC Therapeutics SA is not included in the Dow Jones index

When was ADC Therapeutics SA's last earnings report?

ADC Therapeutics SA's most recent earnings report was on Mar 27, 2025

When does ADC Therapeutics SA report earnings?

The next expected earnings date for ADC Therapeutics SA is May 6, 2025

Should I buy ADC Therapeutics SA stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page